Vaxcyte, Inc. PCVX
NASDAQ · United States · Health Technology
$56.82-0.09 (-0.15%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.97 | -2.06 | +4.2% | $0 | — | +7.7%$54.69→$58.89 |
| Q1 2026 | 2026-05-06 | -2.30 | -1.86 | -23.7% | — | — | -7.5%$55.64→$51.48 |
| Q4 2025 | 2026-02-24 | -1.80 | -1.50 | -20.0% | — | — | +4.6%$60.26→$63.04 |
| Q3 2025 | 2025-11-04 | -1.56 | -1.27 | -22.8% | — | — | -5.9%$42.83→$40.32 |
| Q4 2024 | 2025-02-25 | -1.02 | -0.99 | -3.0% | — | — | — |
| Q3 2024 | 2024-11-05 | -0.83 | -0.99 | +16.2% | — | — | — |
| Q4 2023 | 2024-02-27 | -1.82 | -0.99 | -83.8% | — | — | — |
| Q3 2023 | 2023-11-06 | -0.91 | -0.84 | -8.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.